RSS
VFMCRP
Relypsa forms partnership for hyperkalaemia treatment
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Relypsa, have announced a partnership to commercialise Relypsa's investigational medicine for the treatment of hyperkalaemia Read more
